Hadi Esmaily

1.5k total citations
68 papers, 1.2k citations indexed

About

Hadi Esmaily is a scholar working on Molecular Biology, Plant Science and Surgery. According to data from OpenAlex, Hadi Esmaily has authored 68 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Plant Science and 9 papers in Surgery. Recurrent topics in Hadi Esmaily's work include Pharmacological Effects of Natural Compounds (6 papers), Pesticide Exposure and Toxicity (5 papers) and Silymarin and Mushroom Poisoning (5 papers). Hadi Esmaily is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Pesticide Exposure and Toxicity (5 papers) and Silymarin and Mushroom Poisoning (5 papers). Hadi Esmaily collaborates with scholars based in Iran, Switzerland and United States. Hadi Esmaily's co-authors include Mohammad Abdollahı, Azadeh Mohammadirad, Maryam Baeeri, Atousa Aliahmadi, Abdolkarim Pajoumand, Hossein Hassanian‐Moghaddam, Shahin Shadnia, Reza Khorasani, Seyed Nasser Ostad and Ahmad Reza Shahverdi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Pharmaceutical Sciences and World Journal of Gastroenterology.

In The Last Decade

Hadi Esmaily

57 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadi Esmaily Iran 22 284 217 170 134 116 68 1.2k
Adam Szeląg Poland 24 152 0.5× 462 2.1× 214 1.3× 163 1.2× 122 1.1× 128 1.7k
Nagla A. El‐Shitany Egypt 20 167 0.6× 337 1.6× 199 1.2× 137 1.0× 139 1.2× 51 1.5k
Bongani B. Nkambule South Africa 27 168 0.6× 641 3.0× 155 0.9× 190 1.4× 134 1.2× 122 2.3k
Ömer Çoşkun Türkiye 24 209 0.7× 257 1.2× 222 1.3× 238 1.8× 141 1.2× 74 1.8k
Abdul Hafeez Saudi Arabia 23 301 1.1× 377 1.7× 145 0.9× 197 1.5× 109 0.9× 106 2.9k
Azadeh Mohammadirad Iran 25 573 2.0× 396 1.8× 242 1.4× 110 0.8× 175 1.5× 44 1.8k
Mohammad Moshiri Iran 14 135 0.5× 234 1.1× 150 0.9× 101 0.8× 122 1.1× 82 1.0k
Soad Shaker Ali Saudi Arabia 19 196 0.7× 207 1.0× 118 0.7× 147 1.1× 90 0.8× 92 1.3k
Navpreet Kaur India 20 150 0.5× 200 0.9× 179 1.1× 232 1.7× 176 1.5× 133 1.6k
Carlos Pascual Spain 24 139 0.5× 311 1.4× 84 0.5× 121 0.9× 57 0.5× 95 2.1k

Countries citing papers authored by Hadi Esmaily

Since Specialization
Citations

This map shows the geographic impact of Hadi Esmaily's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadi Esmaily with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadi Esmaily more than expected).

Fields of papers citing papers by Hadi Esmaily

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadi Esmaily. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadi Esmaily. The network helps show where Hadi Esmaily may publish in the future.

Co-authorship network of co-authors of Hadi Esmaily

This figure shows the co-authorship network connecting the top 25 collaborators of Hadi Esmaily. A scholar is included among the top collaborators of Hadi Esmaily based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadi Esmaily. Hadi Esmaily is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kashani, Hamid Reza Khayat, et al.. (2025). Rivaroxaban versus enoxaparin as thromboprophylaxis in degenerative spine surgery: a randomized blinded non-inferiority study. European Spine Journal. 34(5). 1926–1933.
2.
Esmaily, Hadi, et al.. (2025). Treatment Efficacy in Herpes Zoster Ophthalmoplegia: A Systematic Review and Meta‐Analysis of Case Reports and Series. Reviews in Medical Virology. 35(4). e70044–e70044.
3.
4.
Assarzadegan, Farhad, et al.. (2024). The effect of crocin on movement disorders and oxidative DNA damage in Parkinson's disease: Insights from a randomized controlled trial. Parkinsonism & Related Disorders. 126. 107051–107051. 4 indexed citations
5.
Esmaily, Hadi, et al.. (2024). Atezolizumab and Bevacizumab Targeted-Therapy in Advanced Hepatocellular Carcinoma: A Systematic Review of Cost-effectiveness Analyses. Journal of Gastrointestinal Cancer. 55(2). 625–637. 6 indexed citations
6.
Assarzadegan, Farhad, et al.. (2024). Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial. Headache The Journal of Head and Face Pain. 65(1). 153–163. 1 indexed citations
7.
Assarzadegan, Farhad, et al.. (2023). Efficacy of Probiotics in Improving Motor Function and Alleviating Constipation in Parkinson’s Disease: A Randomized Controlled Trial. Iranian journal of pharmaceutical research. 22(1). e137840–e137840. 17 indexed citations
8.
Seydi, Enayatollah, et al.. (2023). Mitochondrial transplantation attenuates toxicity in rat renal proximal tubular cells caused by Favipiravir. Journal of Pharmacy and Pharmacology. 75(11). 1458–1466. 8 indexed citations
9.
Nasimi, Maryam, et al.. (2023). Comparing the efficacy of three methods of permethrin application in pediculosis capitis: A randomized clinical trial. Journal of Cosmetic Dermatology. 22(11). 3065–3071.
10.
Assarzadegan, Farhad, et al.. (2023). Evaluating the effectiveness of probiotics in relieving constipation in Parkinson’s disease: A systematic review and meta-analysis. Heliyon. 9(3). e14312–e14312. 12 indexed citations
11.
Abbasinazari, Mohammad, et al.. (2022). Case report: Bilateral simple Syndactyly in a toddler with maternal exposure to cabergoline. SHILAP Revista de lepidopterología. 10(5). e05795–e05795. 2 indexed citations
12.
Tolouian, Ramin, Zuber D. Mulla, Mehrdad Haghighi, et al.. (2022). Bromhexine for Post-exposure COVID-19 Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial. Jundishapur Journal of Microbiology. 15(8). 1 indexed citations
13.
Esmaily, Hadi, et al.. (2020). Ultrasound-Guided Injection of High Molecular Weight Hyaluronic Acid versus Corticosteroid in Management of Plantar Fasciitis: A 24-Week Randomized Clinical Trial. SHILAP Revista de lepidopterología. 4 indexed citations
14.
Esmaily, Hadi, et al.. (2014). Induction of Inflammatory Bowel Disease Through Activation of Immune System Against Enteric Bacteria. Journal of Gastroenterology and Hepatology Research. 3(2). 977–984. 1 indexed citations
15.
Esmaily, Hadi, et al.. (2014). THE EFFECT OF FAMILY’S SUPPORTIVE PRESENCE ON THE RECOVERY OF PATIENTS WITH BRAIN INJURY IN INTENSIVE CARE UNIT: A RANDOMIZED CLINICAL TRIAL. Faṣlnāmah-i dānishkadah-i parastāri va māmāyī-i Urūmiyyah/Faṣlnāmah-i dānishkadah-i parastāri va māmāyī-i Urūmiyyah.. 11(12). 0–0. 5 indexed citations
16.
Esmaily, Hadi, et al.. (2011). Amelioration of experimental colitis by a novel nanoselenium–silymarin mixture. Toxicology Mechanisms and Methods. 21(3). 200–208. 77 indexed citations
17.
Abdollahı, Mohammad, et al.. (2011). Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharmacognosy Magazine. 7(27). 213–213. 40 indexed citations
18.
Esmaily, Hadi, et al.. (2010). The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis. Fundamental and Clinical Pharmacology. 25(6). 723–733. 31 indexed citations
19.
Jafarzadeh, Mostafa, et al.. (2009). Prevalence of glucose-6-phosphate dehydrogenase deficiency in neonates of Northeast of Iran.. 4(8). 448–451. 6 indexed citations
20.
Najafabadi, Abdolhossien Rouholamini, et al.. (2008). Effect of dimethyl‐β‐cyclodextrin concentrations on the pulmonary delivery of recombinant human growth hormone dry powder in rats. Journal of Pharmaceutical Sciences. 97(12). 5176–5185. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adam Szeląg Breakdown of academic impact, for papers by Nagla A. El‐Shitany Breakdown of academic impact, for papers by Bongani B. Nkambule Breakdown of academic impact, for papers by Ömer Çoşkun Breakdown of academic impact, for papers by Abdul Hafeez Breakdown of academic impact, for papers by Azadeh Mohammadirad Breakdown of academic impact, for papers by Mohammad Moshiri Breakdown of academic impact, for papers by Soad Shaker Ali Breakdown of academic impact, for papers by Navpreet Kaur Breakdown of academic impact, for papers by Carlos Pascual
Rankless by CCL
2026